ESSA Pharma
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -22 | -15 | -29 | -27 |
EBITDA | -7,211 | -8,974 | -5,934 | -5,453 |
EBIT | -7,233 | -8,989 | -5,964 | -5,480 |
Net Income | -7,233 | -8,989 | -5,964 | -5,481 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,745 | -6,886 | -6,787 | -4,488 |
Cash | 85,985 | 91,683 | 35,344 | 33,701 |
Basic Shares | 44,365 | 44,237 | 44,129 | 44,100 |
Annual Financials
| Values in thousands | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -118 | -121 | -109 | -110 |
EBITDA | -26,455 | -35,079 | -36,708 | -23,005 |
EBIT | -26,573 | -35,201 | -36,817 | -23,115 |
Net Income | -26,582 | -35,103 | -36,805 | -23,445 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,781 | -28,704 | -25,415 | -16,983 |
Cash | 33,701 | 57,076 | 137,825 | 56,321 |
Basic Shares | 44,089 | 44,038 | 38,480 | 22,443 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.16 |
2024-03-31 | -$0.20 |
2023-12-31 | -$0.14 |
2023-09-30 | -$0.12 |
